Review Article

Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients

Table 8

Efficacy of PGAs in LNRs.

Number of trialsBIM (N)TRA (N)LAT (N)WMD (95%CI)Test for heterogeneityTest for overall effect

BIM vs. LAT2460444.153 (0.245, 8.062)Q = 9.63, Z = 2.08,
BIM vs. TRA216215800.695 (0.114, 1.277)Q = 0.01, Z = 2.34,
TRA vs. LAT1023291.400 (−1.360, 4.160)N. AZ = 0.99,

BIM: bimatoprost, TRA: travoprost, LAT: latanoprost.